Chemically Defined Serum-Free Medium for Mammary Epithelial Cell Propagation

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current methods struggle to effectively propagate and transform human mammary epithelial cells in vitro, leading to rare and unrealistic tumor phenotypes, as existing media fail to isolate and maintain primary cells without genetic alterations, and traditional xenograft models do not accurately recapitulate human breast cancer characteristics.

Innovation Solution

A chemically defined, serum-free medium formulation that supports the growth and differentiation of primary mammary epithelial progenitor cells, allowing for the transformation into tumorigenic cells that mimic human breast cancer stem cells, enabling the creation of genetically defined tumor models that exhibit metastatic and hormone-responsive behaviors.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If traditional serum-containing media are used to propagate human mammary epithelial cells, then cell growth is supported, but genetic alterations occur and tumor phenotypes become unrealistic

Engineering Contradiction:

Improvecell propagation efficiencyVSAvoidgenetic stability and tumor phenotype accuracy

Core Design Contradiction:

ProductivityVSReliability

Solution Approach 1:

The invention changes the chemical composition parameters of the culture medium by eliminating serum and replacing it with a chemically defined formulation containing specific growth factors (EGF, insulin, hydrocortisone, cholera toxin) at precise concentrations. This parameter change maintains cell propagation efficiency while preventing genetic alterations and preserving accurate tumor phenotype representation.

Inventive Principle:

Principle #35Parameter changes

Solution Approach 2:

The invention replaces expensive, variable serum components with a cost-effective, chemically defined medium formulation that can be precisely controlled and reproduced. This disposable-like approach to medium composition ensures consistent results without the contamination and genetic instability introduced by serum.

Inventive Principle:

Principle #27Cheap short-living objects (Disposable)

2Ease of operation

If existing media formulations are used, then cell culture is simplified, but the ability to isolate and maintain primary cells without genetic alterations is lost

Engineering Contradiction:

Improvecell culture simplicityVSAvoidprimary cell integrity and genetic stability

Core Design Contradiction:

Ease of operationVSReliability

Solution Approach 1:

The invention modifies the medium composition parameters to create a chemically defined formulation that is both simple to use and effective at maintaining primary cell integrity. The specific combination of growth factors and hormones at defined concentrations provides this dual benefit.

Inventive Principle:

Principle #35Parameter changes

3Productivity

If traditional xenograft models are used, then tumor formation can be achieved, but accurate recapitulation of human breast cancer characteristics is not realized

Engineering Contradiction:

Improvetumor formation capabilityVSAvoidtumor phenotype accuracy and hormone responsiveness

Core Design Contradiction:

ProductivityVSManufacturing precision

Solution Approach 1:

The invention performs preliminary action by culturing and transforming human mammary epithelial cells in a chemically defined medium before xenografting. This preliminary transformation in an accurate cellular environment ensures that the resulting xenograft tumors accurately recapitulate human breast cancer characteristics, including hormone responsiveness and metastatic behavior.

Inventive Principle:

Principle #10Preliminary action

Solution Approach 2:

The invention changes the cellular parameters (genetic stability, differentiation state) through chemically defined medium culture, which subsequently enables the xenograft model to accurately reflect human breast cancer characteristics rather than producing unrealistic tumor phenotypes.

Inventive Principle:

Principle #35Parameter changes

4Productivity

If serum-containing media are used, then cell proliferation is maintained, but the medium fails to support long-term undifferentiated growth

Engineering Contradiction:

Improvecell proliferation rateVSAvoidlong-term culture duration without differentiation

Core Design Contradiction:

ProductivityVSDuration of action of moving object

Solution Approach 1:

The invention changes the temporal parameters of cell culture by using a chemically defined medium that supports sustained undifferentiated growth over extended periods. The specific growth factor composition prevents differentiation signals that would otherwise occur in serum-containing media, enabling long-term culture while maintaining proliferation.

Inventive Principle:

Principle #35Parameter changes

Data Source

PatentUS11530385B2Hormone responsive tissue culture system and uses thereof

Publication Date: 2022.12.20 WHITEHEAD INST FOR BIOMEDICAL RES

AI summary

The invention provides tissue culture system for primary cells (e.g. normal mammalian primary epithelial progenitors). This system includes: a) a serum-free, chemically defined cell culture media; and, b) methods for isolation and in vitro long-term propagation of primary cells (e.g. primary epithelial cells). Primary cells so isolated and cultured can be kept undifferentiated and proliferate for many weeks (>15 weeks) or population doubling (>35 PD) without senescence, or any detectable genetic alterations. Upon changing media/culture conditions, these cells can be induced to differentiate.The invention also provides methods to transform normal primary cells so cultured into “cancer stem cells.” The genetically defined cancer stem cell tumor model mimics the behavior of the disease closely, e.g., the cells are invasive, hormone responsive and metastatic when injected into mice. The tumor cells express genes that are specific to cancer stem cells identified in patient samples.